Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1985 1
1992 1
1999 1
2002 1
2003 1
2007 1
2008 2
2010 1
2012 2
2013 1
2014 2
2015 1
2016 3
2017 1
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Sardesai SD, Kalinsky K, Zelnak AB, Weaver R, Traina T, Dalenc F, Aftimos P, Lynce F, Diab S, Cortés J, O'Shaughnessy J, Diéras V, Ferrario C, Schmid P, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo MS, Itri LM, Rugo HS; ASCENT Clinical Trial Investigators. Bardia A, et al. N Engl J Med. 2021 Apr 22;384(16):1529-1541. doi: 10.1056/NEJMoa2028485. N Engl J Med. 2021. PMID: 33882206 Clinical Trial.
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895".
Rayson D, Gandhi S, Joy AA, Brezden-Masley C, Gelmon KA, Sehdev S, Cescon D, Chia S. Rayson D, et al. Curr Oncol. 2023 May 16;30(5):5050-5053. doi: 10.3390/curroncol30050381. Curr Oncol. 2023. PMID: 37232839 Free PMC article.
Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis.
Younis T, Rayson D, Thompson K. Younis T, et al. Support Care Cancer. 2012 Oct;20(10):2523-30. doi: 10.1007/s00520-011-1375-6. Epub 2012 Jan 15. Support Care Cancer. 2012. PMID: 22252548 Review.
A systematic review and meta-analysis was conducted to assess: (a) FN rates associated with TC and FEC-D without primary G-CSF prophylaxis outside of clinical trial settings, and (b) the potential impact of G-CSF prophylaxis on FN prevention. ...RESULTS: Nine hundred two p …
A systematic review and meta-analysis was conducted to assess: (a) FN rates associated with TC and FEC-D without primary G-CSF prophy …
Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100.
Younis T, Rayson D, Sellon M, Skedgel C. Younis T, et al. Breast Cancer Res Treat. 2008 Sep;111(2):261-7. doi: 10.1007/s10549-007-9770-x. Epub 2007 Oct 5. Breast Cancer Res Treat. 2008. PMID: 17914669
BACKGROUND: Adjuvant 5-flurouracil, epirubicin and cyclophosphamide-docetaxel (FEC-D) has been shown to improve disease-free and overall survival (DFS and OS), compared to FEC 100, for node-positive breast cancer. An economic evaluation was undertaken to examine the cost-u …
BACKGROUND: Adjuvant 5-flurouracil, epirubicin and cyclophosphamide-docetaxel (FEC-D) has been shown to improve disease-free and over …
Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review.
Younis T, Rayson D, Jovanovic S, Skedgel C. Younis T, et al. Breast Cancer Res Treat. 2016 Oct;159(3):425-32. doi: 10.1007/s10549-016-3954-1. Epub 2016 Aug 30. Breast Cancer Res Treat. 2016. PMID: 27572552 Review.
Five relevant CEA/CUA were identified. These CEA/CUA examined different AC regimens (TAC = 2; FEC-D = 1; TC = 2) and G-CSF formulations (filgrastim "F" = 4; pegfilgrastim "P" = 4) with varying baseline FN-risk (range 22-32 %), mortality (range 1.4-6.0 %) and utility (range …
Five relevant CEA/CUA were identified. These CEA/CUA examined different AC regimens (TAC = 2; FEC-D = 1; TC = 2) and G-CSF formulatio …
Incidence of febrile neutropenia in early stage breast cancer patients receiving adjuvant FEC-D treatment.
Assi H, Murray J, Boyle L, Rayson D. Assi H, et al. Support Care Cancer. 2014 Dec;22(12):3227-34. doi: 10.1007/s00520-014-2318-9. Epub 2014 Jul 5. Support Care Cancer. 2014. PMID: 24996828
RESULTS: Of 520 patients enrolled in the database, 251 (48.3 %) received adjuvant chemotherapy for ESBC. Most (66.9 %) received FEC-D. Overall, 55 (21.9 %) patients developed FN. Forty-four (26.2 %) patients on FEC-D developed FN. ...Consistent with ASCO guidelines, …
RESULTS: Of 520 patients enrolled in the database, 251 (48.3 %) received adjuvant chemotherapy for ESBC. Most (66.9 %) received FEC-D …
Energy balance and physical demands during an 8-week arduous military training course.
Richmond VL, Horner FE, Wilkinson DM, Rayson MP, Wright A, Izard R. Richmond VL, et al. Mil Med. 2014 Apr;179(4):421-7. doi: 10.7205/MILMED-D-13-00313. Mil Med. 2014. PMID: 24690967
This average weight loss equates to an estimated energy deficit of 2.69 MJ . d(-1). The Army provided an estimated 14.0 2.2 MJ . d(-1) in weeks 2 to 3 and 15.7 2.2 MJ . d(-1) in weeks 6 to 7. Although this provision adheres to the minimum requirement of 13.8 …
This average weight loss equates to an estimated energy deficit of 2.69 MJ . d(-1). The Army provided an estimated 14.0 2.2 MJ . d …
23 results